If mega-rich people could buy places on clinical trials, would this help drive forward the development of new treatments that could benefit everyone? Alexander Masters thinks it might just work.
How do you tell someone that they’re seriously ill, or even dying? Chrissie Giles explores how doctors learn and how they deal with the stress and trauma, for both their patients and themselves.
In the 1970s, radical scientists thought they could change the world – if they could change science first. As told to Alice Bell.
Surgery to remove the fallopian tubes but spare the ovaries of women predisposed to cancer may prevent early menopause, but is it irresponsible? Charlotte Huff explores the costs of buying time.
Medical cannabis is legal in places as diverse as Canada, Uruguay, Israel and Jamaica. But could legalisation work in the UK? Katharine Quarmby finds out.
Sharing breast milk is not new, but will rising demand – and supply – change the relationship between milk donors and the mothers whose babies need it? Carrie Arnold reports.
Traditionally, expectant mothers have been excluded from clinical trials, but could this practice be doing more harm than good? Emily Anthes investigates.
What drives the partners of men who have died to try and have their babies? Jenny Morber delves into the legally and ethically fraught world of post-mortem sperm donation.
When Judy Refuerzo heard the word ‘carcinoma’, she began considering her treatment options. But two years on, she’s chosen surveillance over surgery. Charlotte Huff meets her and other so-called watchful waiters.
Bringing genetics into medicine leads to more accuracy, better diagnosis and personalised treatment – but not for everyone. Carrie Arnold meets families for whom gene testing has led only to unanswered questions.
Rebecca Grant reports on the ethics and law of consent in the delivery room.
When discussing death, the words we choose can speak volumes.
How does a doctor train to break bad news? By acting the part.
The 1970s saw a boom in both scientific and environmental activism. But some considered the greens too right-wing.
Could an addition to routine pelvic surgery help protect women from ovarian cancer?
A look at the different methods some patients use to take cannabis for medical reasons.
Why was medical cannabis banned in the UK? Katharine Quarmby uncovers the history.
What if there were a crowd-sourced library of rare cancer samples, ordered simply using ‘one-click shopping’?
Carrie Arnold charts the history of donated breast milk in the US.
New US drug labels are trying to reduce confusion around safety in pregnancy.
In a talk for 5x15, Alexander Masters describes his personal journey setting up an unlikely ‘dating agency’ to match neglected research for desperately needed drugs for rare cancers with the mega rich that might just fund it.
Genetic variants that cause disease are rare, but this does not mean that all rare variants cause disease. So should we change the way we manage uncertainty in genetic testing?
How can you get advice on which drugs are safe in pregnancy?
Our survey of people in the UK living with chronic, long-term or life-limiting conditions.
Genetic diagnosis is getting ever more sophisticated. But as doctors uncover diseases that are hereditary, who needs to know?
This reading list accompanies our story on the ethical issues around sharing genetic information.
Laws are being passed to compel people to receive treatment for health problems they don’t believe they have.
This reading list accompanies our story on treating people for health problems that they don’t believe they have.